Global Immunoglobulin Products Market 2016-2020

Detailed TOC of Global Immunoglobulin Products Market 2016-2020

PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
• Assumptions
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Plasma products: An overview
• Components of blood plasma
• Manufacturing process of plasma products
• Clinical uses of plasma
• Cost of plasma therapeutics
PART 06: Regulation of plasma products
PART 07: Pipeline portfolio
• Information on few pipeline candidates
PART 08: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 09: Market segmentation by type of immunoglobulins
PART 10: Market segmentation by application
• Immunodeficiency diseases
• Hypogammaglobulinemia
• CIDP
• Congenital AIDS
• CLL
• Myasthenia gravis
• MMN
• ITP
• Kawasaki disease
• Guillain–Barré syndrome
• Others
PART 11: Market segmentation by ROA
• IVIG products
• SCIG products
• IMIG products
PART 12: Market segmentation by volume
• Market overview
• Immunoglobulin products market by volume in Americas
• Immunoglobulin products market by volume in EMEA
• Immunoglobulin products market by volume in APAC
PART 13: Geographical segmentation
• Immunoglobulin products market in Americas
• Immunoglobulin products market in EMEA
• Immunoglobulin products market in APAC
PART 14: Market drivers
• Growing older population
• Increase in individuals with PID
• Promising pipeline
• Approval of immunoglobulins to treat neuroimmunological disorders
• Rise in demand for IVIG therapies
PART 15: Impact of drivers
PART 16: Market challenges
• High cost of therapy
• Product recalls by US FDA
• Limited plasma fractionation capacity
• Post-transfusion adverse reactions
• Stringent regulatory guidelines
PART 17: Impact of drivers and challenges
PART 18: Market trends
• Patient assistance programs
• Strategic alliances and M&A
• Increased use of synthetic/recombinant products
• Rise in awareness of PID
PART 19: Vendor landscape
• Competitive scenario
• Market share analysis 2015
• CSL
• Baxalta
• Grifols
• Octapharma
• Kedrion
• Biotest Pharmaceuticals
• Other prominent vendors
PART 20: Appendix
• List of abbreviations
PART 21: Explore Technavio
 
List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Composition of blood
Exhibit 03: Composition of plasma
Exhibit 04: Total collection of plasma in US 2010-2014 (in liters)
Exhibit 05: Projected fractionation capacity of manufacturing units in US and EU (millions of liters/annum)
Exhibit 06: Process of procurement and manufacturing of plasma products
Exhibit 07: Regulatory policies of plasma protein therapy lifecycle
Exhibit 08: Pipeline molecules for immunoglobulin products
Exhibit 09: Pipeline share of immunoglobulin products 2015
Exhibit 10: Global immunoglobulin products market 2015-2020 ($ billions)
Exhibit 11: Five forces analysis
Exhibit 12: Global immunoglobulin products market segment by type of immunoglobulins
Exhibit 13: Global immunoglobulin products market share by type of immunoglobulins 2015
Exhibit 14: Global immunoglobulin products market segmentation by application
Exhibit 15: Global immunoglobulin products market share by application
Exhibit 16: Global immunoglobulin products market segment by ROA
Exhibit 17: Global immunoglobulin products market share by ROA2015
Exhibit 18: Global IVIG products market 2015-2020 ($ billions)
Exhibit 19: Global SCIG products market 2015-2020 ($ billions)
Exhibit 20: Global IMIG products market 2015-2020 ($ billions)
Exhibit 21: Global immunoglobulin products market revenue by ROA 2015-2020 ($ billions)
Exhibit 22: Global immunoglobulin products market YoY revenue and growth based on ROA 2015-2020 ($ billions)
Exhibit 23: Global immunoglobulin products market by volume 2015
Exhibit 24: Global immunoglobulin products by volume 2015 and 2020 (tons)
Exhibit 25: Global immunoglobulin products market by volume 2015-2020 (tons)
Exhibit 26: Average immunoglobulin consumption by country (Kilograms per million people) 2012
Exhibit 27: Immunoglobulin products market in Americas by volume 2015-2020 (tons)
Exhibit 28: Global immunoglobulin products market by volume 2015-2020 (tons)
Exhibit 29: Immunoglobulin products market in EMEA by volume 2015-2020 (tons)
Exhibit 30: Global immunoglobulin products market by geography 2015
Exhibit 31: Global immunoglobulin products market revenue by geography 2015-2020 ($ billions)
Exhibit 32: Immunoglobulin products market in Americas 2015-2020 ($ billions)
Exhibit 33: Immunoglobulin products market in EMEA 2015-2020 ($ billions)
Exhibit 34: Immunoglobulin products market in APAC 2015-2020 ($ billions)
Exhibit 35: Global immunoglobulin products market YoY revenue and growth based on geography 2015-2020
Exhibit 36: Population aged 60 years and over: World, developed, and developing regions (millions)
Exhibit 37: Impact of drivers
Exhibit 38: Impact of drivers and challenges
Exhibit 39: Global immunoglobulin products market share analysis 2015
Exhibit 40: Market share analysis of top vendors 2015
Exhibit 41: CSL: Immunoglobulins products segmentation
Exhibit 42: Key takeaways
Exhibit 43: Baxalta: Product categories by revenue 2015
Exhibit 44: Baxalta: YoY revenue comparison of immunoglobulin therapy area 2014 and 2015
Exhibit 45: Baxalta: Geographic segmentation of immunoglobulin therapies by revenue 2015
Exhibit 46: CSL: Key takeaways
Exhibit 47: Grifols: YoY growth rate and revenue of bioscience segment 2013-2015 ($ billions)
Exhibit 48: Grifols: Key takeaways
Exhibit 49: Octapharma: Key takeaways
Exhibit 50: Kedrion: Key takeaways
Exhibit 51: Biotest: Key takeaways